Compliance With LDL-Lowering Therapy (Study P05467)(COMPLETED)

This observational study is being conducted in patients receiving statin treatment as secondary prevention of coronary heart disease under the current standard of care in compliance with European guidelines. The purpose of the study is to evaluate the percentage of these patients that reach target LDL levels. Additionally this study will measure the patient's compliance to treatment as assessed by counting the returned tablets. Both assessments will be made at visits conducted 6-8 weeks after the first visit and 28-32 weeks after the first visit.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Coronary Heart Disease Cardiovascular Diseases Coronary Disease Dyslipidemias Heart Diseases Hypercholesterolemia Hyperlipidemia Hyperlipidemias Lipid Metabolism Disorders Metabolic Diseases Myocardial Ischemia Nutritional and Metabolic Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

willingness to participate in the study
18 years of age or more
clinically established cardiovascular disease to be considered as patients in secondary prevention
prior therapy with any statin without achieving goal (2.5 mmol/L of LDL cholesterol) at last lipid check performed

Exclusion criteria

None

Treatment and study plan

Statin

Drug

Statin

Primary outcomes

percentage of patients reaching target LDL levels

Time frame: 6-8 weeks after first visit and 28-32 weeks after first visit

Secondary outcomes

measure patient compliance to treatment as assessed by counting returned tablets

Time frame: 6-8 weeks after first visit and 28-32 weeks after first visit

Sponsors and collaborators

Lead sponsor

Organon and Co

Industry

Collaborators

Merck Sharp & Dohme LLC

Registry information

Official study title

Compliance With LDL-Lowering Therapy For Secondary Prevention of Coronary Heart Disease in Real Life Practice

Important dates

Study start: 2008
Primary completion: 2009
Study completion: 2009
First posted: Jul 29, 2008
Registry last updated: Feb 16, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed